Epigenomic targets for the treatment of respiratory disease
Authors:
- Rayleen V BowmanRBRayleen V Bowman
- Casey M WrightCWCasey M Wright
- Morgan R DavidsonMDMorgan R Davidson
- Santiyagu M Savarimuthu FrancisSFSantiyagu M Savarimuthu Francis
- Ian A YangIYIan A Yang
- Kwun M FongKFKwun M Fong
- 2 May 2009
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Therapeutic Targets
- Vol. 13 (6) , 625-640
Abstract
A number of processes lead to epigenetic and epigenomic modifications. To address the importance of epigenomics in respiratory disease. Studies of epigenomics were analysed in relation to chronic respiratory diseases. In lung cancer and mesothelioma, a number of genes involved in carcinogenesis have been demonstrated to be hypermethylated, implicating epigenomic changes in the aetiology of these cancers. Hypermethylated genes have also been associated with lung cancer recurrence, indicating epigenomic regulation of metastasis. In airway diseases, modulation of histone function may activate inflammatory mechanisms in chronic obstructive pulmonary disease patients and lead to relative steroid resistance. There is emerging evidence for the role of epigenetic changes in chronic lung diseases such as asthma, including responses to environmental exposures in utero and to the effects of air pollution. Insight into epigenomics will lead to the development of novel biomarkers and treatment targets in respiratory diseases.Keywords
This publication has 133 references indexed in Scilit:
- A microRNA DNA methylation signature for human cancer metastasisProceedings of the National Academy of Sciences, 2008
- DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinomaBritish Journal of Cancer, 2008
- Expression of methylation-related genes is associated with overall survival in patients with non-small cell lung cancerBritish Journal of Cancer, 2008
- Germ-line mutations, DNA damage, and global hypermethylation in mice exposed to particulate air pollution in an urban/industrial locationProceedings of the National Academy of Sciences, 2008
- DNA methylation profile of 28 potential marker loci in malignant mesotheliomaLung Cancer, 2007
- Predicting gene promoter methylation in non-small-cell lung cancer by evaluating sputum and serumBritish Journal of Cancer, 2007
- Hypermethylation of CpG island loci and hypomethylation of LINE‐1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological featuresThe Journal of Pathology, 2006
- Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancerNature Genetics, 2005
- DNA methylation in cancer: too much, but also too littleOncogene, 2002
- Aberrant CpG-island methylation has non-random and tumour-type–specific patternsNature Genetics, 2000